Skip to main content
# Title Research Year
1 Role of Prothrombin and Methylenetetrahydrofolate Reductase Gene Polymorphisms as well as Thrombophilia Markers, as Risk Factors for Unexplained Recurrent Miscarriage: A Case-Control Study 2025
2 Evaluation of Circulating MicroRNA-130b as a novel non-invasive biomarker for hepatocellular carcinoma 2025
3 Value of fibrinogen, fibrinogen to albumin ratio, and blood cell-derived inflammatory indices in patients with systemic sclerosis: A case–control study 2025
4 Plasma Metadherin mRNA expression in Bladder Cancer 2024
5 Assessment of long noncoding RNA CCAT1 using real time-polymerase chain reaction in colorectal cancer patients 2024
6 The Assesment of Matrix Metalloproteinase-1 Genotypes Polymorphism as a Risk Factor For Hepatocellular Carcinoma in Chronic Hepatitis C Patients with Liver Cirrhosis 2024
7 Study of MicroRNA-124 in Patients with Lupus Nephritis. 2024
8 The role of circulating cell-free DNA and its integrity as a biomarker for diagnosis of breast cancer using ALU (247/115) bP sequences 2023
9 Plasma brain natriuretic peptide, D-Dimer, and serum troponin-I as predictors for in-hospital death in patients with COVID-19 2023
10 Effects of preoperative intravenous glutamine administration on cardiac and renal functions in patients undergoing mitral valve replacement surgeries: A randomized double-blind controlled trial 2023